生物技術和製藥服務外包市場：按服務、最終用戶分類 - 全球預測 2023-2030 年

全球生物技術和製藥服務外包市場預計到 2023 年將大幅成長，達到 1508.2 億美元，年複合成長率為 11.77%，預計到 2030 年將達到驚人的 3301.7 億美元。

FPNV定位矩陣

FPNV定位矩陣對於評估全球生物技術和製藥服務外包市場至關重要。通過檢查業務戰略和產品滿意度的關鍵指標，我們對供應商進行全面評估，使您能夠根據您的具體需求做出明智的資訊。這種高級分析將供應商分為四個像限，並取得了不同程度的成功：前沿 (F)、探路者 (P)、利基 (N) 和重要 (V)。

市場佔有率分析

市場佔有率分析可以深入了解供應商在特定市場領域的當前地位。比較供應商對總收入、基本客群和其他關鍵指標的貢獻，可以幫助公司更好地了解他們在爭奪市場佔有率時的表現以及面臨的情況。該分析還揭示了特定行業的競爭程度、積累和合併的優勢以及研究基準年的合併特徵。

本報告提供了以下幾點見解：

1. 市場滲透率：提供有關主要企業所服務的市場的全面資訊。

2. 市場開發：提供有關利潤豐厚的新興市場的詳細資訊，並分析其在成熟市場的滲透率。

3. 市場多元化：提供有關新產品發布、未開發地區、最新發展和投資的詳細資訊。

4.市場趨勢：全面了解COVID-19、俄羅斯-烏克蘭衝突和高通貨膨脹的累積影響。

5、競爭評估與資訊：對主要企業的市場佔有率、戰略、產品、認證、法規狀況、專利狀況、製造能力等進行綜合評價。

6. 產品開發和創新：提供對未來技術、研發活動和突破性產品開發的見解。

本報告回答了以下問題：

1. 全球生物技術和醫藥服務外包市場規模和預測是多少？

2.在預測期內，COVID-19 對全球生物技術和製藥服務外包市場的抑制要素和影響是什麼？

3. 在預測期內，全球生物技術和製藥服務外包市場需要投資哪些產品/細分市場/應用/領域？

4、全球生物技術和醫藥服務外包市場的競爭策略是什麼？

5. 全球生物技術和醫藥服務外包市場的技術趨勢和法律規範是什麼？

6. 全球生物技術和製藥服務外包市場主要供應商的市場佔有率是多少？

7. 哪些型態和戰略舉措被認為適合進入全球生物技術和製藥服務外包市場？

目錄

第1章 前言

第2章 調查方法

第3章 執行摘要

第4章 市場概況

第5章 市場洞察

• 市場動態
  • 促進因素
    • 製藥和生物製藥行業的研發成本增加
    • 藥物開發外包服務的需求不斷成長
    • 擴大標籤和文件等法規支持活動
  • 抑制因素
    • 與缺乏監測和標準化相關的問題
  • 機會
    • 學名藥和生物學名藥製造外包的增加
    • 臨床試驗業務外包
  • 課題
    • 與資料安全以及交貨時間和物流成本增加相關的問題
• 市場趨勢
• COVID-19 的累積影響
• 俄羅斯-烏克蘭衝突的累積影響
• 高通貨膨脹的累積效應
• 波特五力分析
• 價值鍊和關鍵路徑分析
• 法律規範
• 客戶客製化

第6章 生物技術和醫藥服務外包市場：按服務分類

• 審核與評估
• 諮詢
  • 品質管理體系諮詢
  • 法規合規性
  • 維修
• 產品設計與開發
• 產品維護
• 產品測試和檢驗
• 法規事宜
  • 臨床試驗申請和產品註冊
  • 合法代表
  • 法規寫作和發布
• 培訓和教育

第7章 生物技術和製藥服務外包市場：按最終用戶分類

• 生物技術公司
• 製藥公司

第8章 美洲生物技術和醫藥服務外包市場

• 阿根廷
• 巴西
• 加拿大
• 墨西哥
• 美國

第9章 亞太生物技術和醫藥服務外包市場

• 澳大利亞
• 中國
• 印度
• 印度尼西亞
• 日本
• 馬來西亞
• 菲律賓
• 新加坡
• 韓國
• 台灣
• 泰國
• 越南

第10章 歐洲、中東和非洲生物技術和醫藥服務外包市場

• 丹麥
• 埃及
• 芬蘭
• 法國
• 德國
• 以色列
• 義大利
• 荷蘭
• 奈及利亞
• 挪威
• 波蘭
• 卡達
• 俄羅斯
• 沙烏地阿拉伯
• 南非
• 西班牙
• 瑞典
• 瑞士
• 土耳其
• 阿拉伯聯合大公國
• 英國

第11章競爭形勢

• FPNV定位矩陣
• 市場佔有率分析：主要企業
• 競爭情景分析：主要企業

第12章上市公司名單

第13章附錄

• 討論指南
• 關於許可和定價

The Global Biotechnology & Pharmaceutical Services Outsourcing Market is forecasted to grow significantly, with a projected USD 150.82 billion in 2023 at a CAGR of 11.77% and expected to reach a staggering USD 330.17 billion by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Biotechnology & Pharmaceutical Services Outsourcing Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Biotechnology & Pharmaceutical Services Outsourcing Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Services, market is studied across Auditing & Assessment, Consulting, Product Design & Development, Product Maintenance, Product Testing & Validation, Regulatory Affairs, and Training & Education. The Consulting is further studied across Quality Management Systems Consulting, Regulatory Compliance, and Remediation. The Regulatory Affairs is further studied across Clinical Trial Applications & Product Registration, Legal Representation, and Regulatory Writing & Publishing. The Auditing & Assessment is projected to witness significant market share during forecast period.

Based on End-User, market is studied across Biotech Companies and Pharmaceutical Companies. The Biotech Companies is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 38.75% in 2022, followed by Europe, Middle East & Africa.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Biotechnology & Pharmaceutical Services Outsourcing Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Biotechnology & Pharmaceutical Services Outsourcing Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Biotechnology & Pharmaceutical Services Outsourcing Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Biotechnology & Pharmaceutical Services Outsourcing Market?

4. What is the competitive strategic window for opportunities in the Global Biotechnology & Pharmaceutical Services Outsourcing Market?

5. What are the technology trends and regulatory frameworks in the Global Biotechnology & Pharmaceutical Services Outsourcing Market?

6. What is the market share of the leading vendors in the Global Biotechnology & Pharmaceutical Services Outsourcing Market?

7. What modes and strategic moves are considered suitable for entering the Global Biotechnology & Pharmaceutical Services Outsourcing Market?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Limitations
• 1.7. Assumptions
• 1.8. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

• 4.1. Introduction
• 4.2. Biotechnology & Pharmaceutical Services Outsourcing Market, by Services, 2022 vs 2030
• 4.3. Biotechnology & Pharmaceutical Services Outsourcing Market, by End-User, 2022 vs 2030
• 4.4. Biotechnology & Pharmaceutical Services Outsourcing Market, by Region, 2022 vs 2030

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing R&D expenditure of pharmaceutical and biopharmaceutical industry
    • 5.1.1.2. Rising demand for outsourcing services in drug development
    • 5.1.1.3. Growing regulatory support activities including labeling and documentation
  • 5.1.2. Restraints
    • 5.1.2.1. Issues associated with monitoring and lack of standardization
  • 5.1.3. Opportunities
    • 5.1.3.1. Rising outsourcing of generics and biosimilar manufacturing
    • 5.1.3.2. Outsourcing of clinical trial activity
  • 5.1.4. Challenges
    • 5.1.4.1. Issues associated with data security and increasing lead time and logistics costs
• 5.2. Market Trends
• 5.3. Cumulative Impact of COVID-19
• 5.4. Cumulative Impact of Russia-Ukraine Conflict
• 5.5. Cumulative Impact of High Inflation
• 5.6. Porter's Five Forces Analysis
  • 5.6.1. Threat of New Entrants
  • 5.6.2. Threat of Substitutes
  • 5.6.3. Bargaining Power of Customers
  • 5.6.4. Bargaining Power of Suppliers
  • 5.6.5. Industry Rivalry
• 5.7. Value Chain & Critical Path Analysis
• 5.8. Regulatory Framework
• 5.9. Client Customization

6. Biotechnology & Pharmaceutical Services Outsourcing Market, by Services

• 6.1. Introduction
• 6.2. Auditing & Assessment
• 6.3. Consulting
  • 6.3.1. Quality Management Systems Consulting
  • 6.3.2. Regulatory Compliance
  • 6.3.3. Remediation
• 6.4. Product Design & Development
• 6.5. Product Maintenance
• 6.6. Product Testing & Validation
• 6.7. Regulatory Affairs
  • 6.7.1. Clinical Trial Applications & Product Registration
  • 6.7.2. Legal Representation
  • 6.7.3. Regulatory Writing & Publishing
• 6.8. Training & Education

7. Biotechnology & Pharmaceutical Services Outsourcing Market, by End-User

• 7.1. Introduction
• 7.2. Biotech Companies
• 7.3. Pharmaceutical Companies

8. Americas Biotechnology & Pharmaceutical Services Outsourcing Market

• 8.1. Introduction
• 8.2. Argentina
• 8.3. Brazil
• 8.4. Canada
• 8.5. Mexico
• 8.6. United States

9. Asia-Pacific Biotechnology & Pharmaceutical Services Outsourcing Market

• 9.1. Introduction
• 9.2. Australia
• 9.3. China
• 9.4. India
• 9.5. Indonesia
• 9.6. Japan
• 9.7. Malaysia
• 9.8. Philippines
• 9.9. Singapore
• 9.10. South Korea
• 9.11. Taiwan
• 9.12. Thailand
• 9.13. Vietnam

10. Europe, Middle East & Africa Biotechnology & Pharmaceutical Services Outsourcing Market

• 10.1. Introduction
• 10.2. Denmark
• 10.3. Egypt
• 10.4. Finland
• 10.5. France
• 10.6. Germany
• 10.7. Israel
• 10.8. Italy
• 10.9. Netherlands
• 10.10. Nigeria
• 10.11. Norway
• 10.12. Poland
• 10.13. Qatar
• 10.14. Russia
• 10.15. Saudi Arabia
• 10.16. South Africa
• 10.17. Spain
• 10.18. Sweden
• 10.19. Switzerland
• 10.20. Turkey
• 10.21. United Arab Emirates
• 10.22. United Kingdom

11. Competitive Landscape

• 11.1. FPNV Positioning Matrix
• 11.2. Market Share Analysis, By Key Player
• 11.3. Competitive Scenario Analysis, By Key Player

12. List of Company Mentioned

13. Appendix

• 13.1. Discussion Guide
• 13.2. License & Pricing

LIST OF FIGURES

• FIGURE 1. BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET RESEARCH PROCESS
• FIGURE 2. BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, 2022 VS 2030
• FIGURE 3. BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICES, 2022 VS 2030 (%)
• FIGURE 5. BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY END-USER, 2022 VS 2030 (%)
• FIGURE 6. BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY REGION, 2022 VS 2030 (%)
• FIGURE 7. BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET DYNAMICS
• FIGURE 8. BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICES, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 9. BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY END-USER, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 10. AMERICAS BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 11. UNITED STATES BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 12. ASIA-PACIFIC BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 13. EUROPE, MIDDLE EAST & AFRICA BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 14. BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET, FPNV POSITIONING MATRIX, 2022
• FIGURE 15. BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

• TABLE 1. BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
• TABLE 3. BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 5. BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY AUDITING & ASSESSMENT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 6. BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY CONSULTING, 2018-2030 (USD MILLION)
• TABLE 7. BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY CONSULTING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 8. BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY QUALITY MANAGEMENT SYSTEMS CONSULTING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY REGULATORY COMPLIANCE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY REMEDIATION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY PRODUCT DESIGN & DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY PRODUCT MAINTENANCE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY PRODUCT TESTING & VALIDATION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY REGULATORY AFFAIRS, 2018-2030 (USD MILLION)
• TABLE 15. BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY REGULATORY AFFAIRS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY CLINICAL TRIAL APPLICATIONS & PRODUCT REGISTRATION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY LEGAL REPRESENTATION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY REGULATORY WRITING & PUBLISHING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY TRAINING & EDUCATION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 21. BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY BIOTECH COMPANIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. AMERICAS BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 24. AMERICAS BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 25. AMERICAS BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY CONSULTING, 2018-2030 (USD MILLION)
• TABLE 26. AMERICAS BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY REGULATORY AFFAIRS, 2018-2030 (USD MILLION)
• TABLE 27. AMERICAS BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 28. ARGENTINA BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 29. ARGENTINA BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY CONSULTING, 2018-2030 (USD MILLION)
• TABLE 30. ARGENTINA BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY REGULATORY AFFAIRS, 2018-2030 (USD MILLION)
• TABLE 31. ARGENTINA BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 32. BRAZIL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 33. BRAZIL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY CONSULTING, 2018-2030 (USD MILLION)
• TABLE 34. BRAZIL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY REGULATORY AFFAIRS, 2018-2030 (USD MILLION)
• TABLE 35. BRAZIL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 36. CANADA BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 37. CANADA BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY CONSULTING, 2018-2030 (USD MILLION)
• TABLE 38. CANADA BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY REGULATORY AFFAIRS, 2018-2030 (USD MILLION)
• TABLE 39. CANADA BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 40. MEXICO BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 41. MEXICO BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY CONSULTING, 2018-2030 (USD MILLION)
• TABLE 42. MEXICO BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY REGULATORY AFFAIRS, 2018-2030 (USD MILLION)
• TABLE 43. MEXICO BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 44. UNITED STATES BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 45. UNITED STATES BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 46. UNITED STATES BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY CONSULTING, 2018-2030 (USD MILLION)
• TABLE 47. UNITED STATES BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY REGULATORY AFFAIRS, 2018-2030 (USD MILLION)
• TABLE 48. UNITED STATES BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 49. ASIA-PACIFIC BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 50. ASIA-PACIFIC BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 51. ASIA-PACIFIC BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY CONSULTING, 2018-2030 (USD MILLION)
• TABLE 52. ASIA-PACIFIC BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY REGULATORY AFFAIRS, 2018-2030 (USD MILLION)
• TABLE 53. ASIA-PACIFIC BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 54. AUSTRALIA BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 55. AUSTRALIA BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY CONSULTING, 2018-2030 (USD MILLION)
• TABLE 56. AUSTRALIA BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY REGULATORY AFFAIRS, 2018-2030 (USD MILLION)
• TABLE 57. AUSTRALIA BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 58. CHINA BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 59. CHINA BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY CONSULTING, 2018-2030 (USD MILLION)
• TABLE 60. CHINA BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY REGULATORY AFFAIRS, 2018-2030 (USD MILLION)
• TABLE 61. CHINA BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 62. INDIA BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 63. INDIA BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY CONSULTING, 2018-2030 (USD MILLION)
• TABLE 64. INDIA BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY REGULATORY AFFAIRS, 2018-2030 (USD MILLION)
• TABLE 65. INDIA BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 66. INDONESIA BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 67. INDONESIA BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY CONSULTING, 2018-2030 (USD MILLION)
• TABLE 68. INDONESIA BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY REGULATORY AFFAIRS, 2018-2030 (USD MILLION)
• TABLE 69. INDONESIA BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 70. JAPAN BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 71. JAPAN BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY CONSULTING, 2018-2030 (USD MILLION)
• TABLE 72. JAPAN BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY REGULATORY AFFAIRS, 2018-2030 (USD MILLION)
• TABLE 73. JAPAN BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 74. MALAYSIA BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 75. MALAYSIA BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY CONSULTING, 2018-2030 (USD MILLION)
• TABLE 76. MALAYSIA BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY REGULATORY AFFAIRS, 2018-2030 (USD MILLION)
• TABLE 77. MALAYSIA BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 78. PHILIPPINES BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 79. PHILIPPINES BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY CONSULTING, 2018-2030 (USD MILLION)
• TABLE 80. PHILIPPINES BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY REGULATORY AFFAIRS, 2018-2030 (USD MILLION)
• TABLE 81. PHILIPPINES BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 82. SINGAPORE BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 83. SINGAPORE BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY CONSULTING, 2018-2030 (USD MILLION)
• TABLE 84. SINGAPORE BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY REGULATORY AFFAIRS, 2018-2030 (USD MILLION)
• TABLE 85. SINGAPORE BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 86. SOUTH KOREA BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 87. SOUTH KOREA BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY CONSULTING, 2018-2030 (USD MILLION)
• TABLE 88. SOUTH KOREA BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY REGULATORY AFFAIRS, 2018-2030 (USD MILLION)
• TABLE 89. SOUTH KOREA BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 90. TAIWAN BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 91. TAIWAN BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY CONSULTING, 2018-2030 (USD MILLION)
• TABLE 92. TAIWAN BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY REGULATORY AFFAIRS, 2018-2030 (USD MILLION)
• TABLE 93. TAIWAN BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 94. THAILAND BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 95. THAILAND BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY CONSULTING, 2018-2030 (USD MILLION)
• TABLE 96. THAILAND BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY REGULATORY AFFAIRS, 2018-2030 (USD MILLION)
• TABLE 97. THAILAND BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 98. VIETNAM BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 99. VIETNAM BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY CONSULTING, 2018-2030 (USD MILLION)
• TABLE 100. VIETNAM BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY REGULATORY AFFAIRS, 2018-2030 (USD MILLION)
• TABLE 101. VIETNAM BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 102. EUROPE, MIDDLE EAST & AFRICA BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 103. EUROPE, MIDDLE EAST & AFRICA BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 104. EUROPE, MIDDLE EAST & AFRICA BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY CONSULTING, 2018-2030 (USD MILLION)
• TABLE 105. EUROPE, MIDDLE EAST & AFRICA BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY REGULATORY AFFAIRS, 2018-2030 (USD MILLION)
• TABLE 106. EUROPE, MIDDLE EAST & AFRICA BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 107. DENMARK BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 108. DENMARK BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY CONSULTING, 2018-2030 (USD MILLION)
• TABLE 109. DENMARK BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY REGULATORY AFFAIRS, 2018-2030 (USD MILLION)
• TABLE 110. DENMARK BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 111. EGYPT BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 112. EGYPT BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY CONSULTING, 2018-2030 (USD MILLION)
• TABLE 113. EGYPT BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY REGULATORY AFFAIRS, 2018-2030 (USD MILLION)
• TABLE 114. EGYPT BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 115. FINLAND BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 116. FINLAND BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY CONSULTING, 2018-2030 (USD MILLION)
• TABLE 117. FINLAND BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY REGULATORY AFFAIRS, 2018-2030 (USD MILLION)
• TABLE 118. FINLAND BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 119. FRANCE BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 120. FRANCE BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY CONSULTING, 2018-2030 (USD MILLION)
• TABLE 121. FRANCE BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY REGULATORY AFFAIRS, 2018-2030 (USD MILLION)
• TABLE 122. FRANCE BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 123. GERMANY BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 124. GERMANY BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY CONSULTING, 2018-2030 (USD MILLION)
• TABLE 125. GERMANY BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY REGULATORY AFFAIRS, 2018-2030 (USD MILLION)
• TABLE 126. GERMANY BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 127. ISRAEL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 128. ISRAEL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY CONSULTING, 2018-2030 (USD MILLION)
• TABLE 129. ISRAEL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY REGULATORY AFFAIRS, 2018-2030 (USD MILLION)
• TABLE 130. ISRAEL BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 131. ITALY BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 132. ITALY BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY CONSULTING, 2018-2030 (USD MILLION)
• TABLE 133. ITALY BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY REGULATORY AFFAIRS, 2018-2030 (USD MILLION)
• TABLE 134. ITALY BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 135. NETHERLANDS BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 136. NETHERLANDS BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY CONSULTING, 2018-2030 (USD MILLION)
• TABLE 137. NETHERLANDS BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY REGULATORY AFFAIRS, 2018-2030 (USD MILLION)
• TABLE 138. NETHERLANDS BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 139. NIGERIA BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 140. NIGERIA BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY CONSULTING, 2018-2030 (USD MILLION)
• TABLE 141. NIGERIA BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY REGULATORY AFFAIRS, 2018-2030 (USD MILLION)
• TABLE 142. NIGERIA BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 143. NORWAY BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 144. NORWAY BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY CONSULTING, 2018-2030 (USD MILLION)
• TABLE 145. NORWAY BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY REGULATORY AFFAIRS, 2018-2030 (USD MILLION)
• TABLE 146. NORWAY BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 147. POLAND BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 148. POLAND BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY CONSULTING, 2018-2030 (USD MILLION)
• TABLE 149. POLAND BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY REGULATORY AFFAIRS, 2018-2030 (USD MILLION)
• TABLE 150. POLAND BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 151. QATAR BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 152. QATAR BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY CONSULTING, 2018-2030 (USD MILLION)
• TABLE 153. QATAR BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY REGULATORY AFFAIRS, 2018-2030 (USD MILLION)
• TABLE 154. QATAR BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 155. RUSSIA BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 156. RUSSIA BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY CONSULTING, 2018-2030 (USD MILLION)
• TABLE 157. RUSSIA BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY REGULATORY AFFAIRS, 2018-2030 (USD MILLION)
• TABLE 158. RUSSIA BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 159. SAUDI ARABIA BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 160. SAUDI ARABIA BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY CONSULTING, 2018-2030 (USD MILLION)
• TABLE 161. SAUDI ARABIA BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY REGULATORY AFFAIRS, 2018-2030 (USD MILLION)
• TABLE 162. SAUDI ARABIA BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 163. SOUTH AFRICA BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 164. SOUTH AFRICA BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY CONSULTING, 2018-2030 (USD MILLION)
• TABLE 165. SOUTH AFRICA BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY REGULATORY AFFAIRS, 2018-2030 (USD MILLION)
• TABLE 166. SOUTH AFRICA BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 167. SPAIN BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 168. SPAIN BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY CONSULTING, 2018-2030 (USD MILLION)
• TABLE 169. SPAIN BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY REGULATORY AFFAIRS, 2018-2030 (USD MILLION)
• TABLE 170. SPAIN BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 171. SWEDEN BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 172. SWEDEN BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY CONSULTING, 2018-2030 (USD MILLION)
• TABLE 173. SWEDEN BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY REGULATORY AFFAIRS, 2018-2030 (USD MILLION)
• TABLE 174. SWEDEN BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 175. SWITZERLAND BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 176. SWITZERLAND BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY CONSULTING, 2018-2030 (USD MILLION)
• TABLE 177. SWITZERLAND BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY REGULATORY AFFAIRS, 2018-2030 (USD MILLION)
• TABLE 178. SWITZERLAND BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 179. TURKEY BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 180. TURKEY BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY CONSULTING, 2018-2030 (USD MILLION)
• TABLE 181. TURKEY BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY REGULATORY AFFAIRS, 2018-2030 (USD MILLION)
• TABLE 182. TURKEY BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 183. UNITED ARAB EMIRATES BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 184. UNITED ARAB EMIRATES BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY CONSULTING, 2018-2030 (USD MILLION)
• TABLE 185. UNITED ARAB EMIRATES BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY REGULATORY AFFAIRS, 2018-2030 (USD MILLION)
• TABLE 186. UNITED ARAB EMIRATES BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 187. UNITED KINGDOM BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 188. UNITED KINGDOM BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY CONSULTING, 2018-2030 (USD MILLION)
• TABLE 189. UNITED KINGDOM BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY REGULATORY AFFAIRS, 2018-2030 (USD MILLION)
• TABLE 190. UNITED KINGDOM BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 191. BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET, FPNV POSITIONING MATRIX, 2022
• TABLE 192. BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET SHARE, BY KEY PLAYER, 2022
• TABLE 193. BIOTECHNOLOGY & PHARMACEUTICAL SERVICES OUTSOURCING MARKET LICENSE & PRICING